• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Introduction to 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one (CAS No. 17357-32-3)

2-bromo-1-(5-bromofuran-2-yl)ethan-1-one, identified by the CAS number 17357-32-3, is a significant compound in the realm of organic synthesis and pharmaceutical research. This heterocyclic ketone features a brominated furan moiety linked to an acetyl group, making it a versatile intermediate in the development of various bioactive molecules. The structural uniqueness of this compound lies in its ability to serve as a precursor for synthesizing complex pharmacophores, particularly in the field of medicinal chemistry.

The bromo substituents on both the furan ring and the ethyl chain enhance the reactivity of 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one, allowing for further functionalization through cross-coupling reactions, nucleophilic substitutions, and other organic transformations. These properties have made it a valuable building block in the synthesis of novel therapeutic agents targeting diverse biological pathways.

In recent years, there has been growing interest in leveraging such halogenated furans for the development of small-molecule inhibitors. For instance, studies have demonstrated the utility of derivatives of 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one in designing molecules that interact with enzymes involved in cancer metabolism. The bromine atoms facilitate palladium-catalyzed coupling reactions, enabling the construction of intricate scaffolds that mimic natural substrates or inhibit key enzymatic activities.

One notable application involves the synthesis of kinase inhibitors, where the furan ring provides a rigid framework conducive to binding at specific pockets within the enzyme active site. The presence of both bromine atoms enhances binding affinity through halogen bonding interactions, a critical factor in drug design. Researchers have reported promising results in modifying 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one to develop potent inhibitors of tyrosine kinases, which play a pivotal role in signal transduction pathways associated with tumor growth and progression.

Additionally, the compound has shown potential in antimicrobial research. The structural motif derived from 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one has been explored as a scaffold for creating novel antibiotics targeting resistant bacterial strains. The bromine atoms contribute to the compound's ability to disrupt bacterial cell wall synthesis or interfere with essential metabolic processes, offering a promising avenue for combating multidrug-resistant pathogens.

The synthesis of 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one typically involves multi-step organic transformations starting from commercially available furans and brominating agents. Advanced synthetic methodologies, such as transition-metal-catalyzed cross-coupling reactions, have been optimized to improve yield and purity. These methods align with modern green chemistry principles by minimizing waste and maximizing atom economy, ensuring sustainable production practices.

The pharmacological relevance of this compound is further underscored by its role in probing receptor-ligand interactions. Computational studies have been conducted to model how derivatives of 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one might bind to biological targets at the molecular level. These simulations have provided insights into optimizing drug-like properties such as solubility, permeability, and metabolic stability, guiding experimental efforts toward more effective therapeutic candidates.

In conclusion, 2-bromo-1-(5-bromofuran-2-yl)ethan-1-one (CAS No. 17357-32-3) represents a cornerstone compound in medicinal chemistry due to its structural versatility and reactivity. Its applications span across anticancer agents, antimicrobial drugs, and enzyme inhibitors, highlighting its broad utility in pharmaceutical research. As synthetic techniques continue to evolve, derivatives of this compound are expected to play an increasingly pivotal role in developing next-generation therapeutics that address unmet medical needs.

• 15109-94-1(2-bromo-1-(2-furyl)ethanone)
• 865367-56-2(ETHANONE, 2-BROMO-1-NAPHTHO[2,1-B]FURAN-2-YL-)
• 3199-50-6(1-(5-Bromofuran-2-yl)ethanone)
• 1634-53-3(2-Bromo-1-(5-methylfuran-2-yl)ethanone)
• 23489-36-3(1-(1-Benzofuran-2-yl)-2-bromoethanone)
• 109610-92-6
• 99834-94-3(1-(5-bromofuran-2-yl)propan-1-one)
• 17357-25-4(Ethanone, 2,2-dibromo-1-(2-furanyl)-)
• 7039-76-1(Ethanone, 2-bromo-1-(5-bromo-2-benzofuranyl)-)
• 77085-50-8(1-Tridecanone, 1-(5-bromo-2-furanyl)-)